Africa (WHO region) vs Burkina Faso: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Burkina Faso
100.0%
in 2024
Africa (WHO region) rank
2nd
Burkina Faso rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Burkina Faso
How they compare
Burkina Faso currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 8 times across 20 shared years of data; in 2005 it was Burkina Faso ahead.
Africa (WHO region) ranks 2nd and Burkina Faso ranks 1st of 11 groups.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.8% | 44.6% | 10.8% | Burkina Faso |
| 2010s | 74.3% | 79.5% | 5.2% | Burkina Faso |
| 2020s | 93.2% | 94.2% | 1.0% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Burkina Faso?
- Burkina Faso, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Burkina Faso?
- 4.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Africa (WHO region) and Burkina Faso?
- 20 years are reported by both, from 2005 to 2024.
- How do Africa (WHO region) and Burkina Faso rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Burkina Faso ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.